Psychotic major depressive disorder and rapid eye movement sleep behavior disorder cooccurring with a pineal cyst: a case report with neuroimaging insights in a 15-year-old female Authors: Yanping Shu, Qin Zhang, Yongzhe Hou, Jiaoying Liu Published: 2025 ABSTRACT AbstractBackgroundPineal cysts are generally incidental findings on neuroimaging, yet recent evidence has suggested potential associations with circadian rhythm disruption, mood disorders, and sleep dysfunction. This report aims to describe a rare case in an adolescent to explore the potential association between pineal gland abnormalities and circadian dysregulation in the pathophysiology of mood and sleep disturbances.Case presentationWe describe a 15-year-old female with a three-year history of depressive symptoms, auditory and visual hallucinations, persecutory delusions, and recurrent self-harm, culminating in multiple suicide attempts. On admission, brain magnetic resonance imaging (MRI) revealed a 7-mm pineal cyst. During hospitalization, polysomnography confirmed rapid eye movement sleep behavior disorder (RBD). Initial treatment with escitalopram, olanzapine, lithium, tandospirone, and lorazepam was complicated by the emergence of RBD, prompting medication adjustments to aripiprazole, clonazepam, and valproate, while escitalopram was continued as the primary antidepressant to minimize RBD-related risks. This change, combined with ten sessions of modified electroconvulsive therapy and supportive psychotherapy, led to significant improvements in mood, psychotic symptoms, suicidality, and sleep continuity. The coexistence of psychotic major depressive disorder, RBD, and a pineal cyst in an adolescent is rare and raises important questions regarding the association between pineal pathology and circadian regulation in patients with psychiatric and sleep disorders.ConclusionsThis case highlights the value of structural neuroimaging in adolescents with psychotic major depressive disorder and underscores the importance of individualized, multimodal treatment planning. Further research is warranted to clarify the clinical significance of pineal abnormalities and their association with mood and sleep disorders.Supplementary InformationThe online version contains supplementary material available at 10.1186/s12888-025-07709-z.Keywords: Pineal cyst, Psychotic major depressive disorder, Rapid eye movement sleep behavior disorder, Neuroimaging, Adolescent psychiatry Introduction Pineal cysts are benign, fluid-filled lesions that are observed in approximately 1.3–4.3% of brain magnetic resonance imaging (MRI) scans and are typically regarded as incidental findings [1]. The pineal gland regulates melatonin secretion and circadian rhythm and may influence mood and sleep physiology. Disruption of these functions has been linked to depression, anxiety, and sleep disturbances. Rapid eye movement (REM) sleep behavior disorder (RBD) is a parasomnia characterized by loss of muscle atonia during REM sleep and dream-enactment behaviors. Although often linked to neurodegenerative disease, it can also occur in younger individuals and has increasingly been recognized in psychiatric populations [2]. While most pineal cysts remain asymptomatic, symptomatic patients often present with headache or visual changes [3]. Psychiatric manifestations are rarely dominant, although Kontoangelos et al. reported on an adult with severe depressive symptoms secondary to a pineal epidermoid cyst [4]. Although the association between pineal cysts and psychiatric disorders remains uncertain, neuroimaging studies have suggested that reduced pineal volume may be associated with major depressive disorder and anhedonia, indicating potential clinical relevance [5]. Reports of psychotic major depressive disorder accompanied by RBD in the context of a pineal cyst are virtually absent in the literature, particularly in adolescents. This observation is of clinical relevance given that adolescence represents a critical developmental window for circadian rhythm stabilization, melatonin secretion, and susceptibility to mood and psychotic disorders. Therefore, the purpose of this report is to present a rare case of psychotic major depressive disorder cooccurring with RBD and a pineal cyst in an adolescent and to discuss the potential associations among pineal abnormalities, circadian dysregulation, and mood–sleep interactions, highlighting the importance of neuroimaging in complex adolescent psychiatric presentations. Case presentation A 15-year-old adolescent female was admitted with a three-year history of persistent low mood, hopelessness, anxiety, and functional decline. Over the preceding year, she had developed auditory hallucinations (a female voice insulting her and urging suicide), visual hallucinations (seeing her deceased grandfather), and persecutory delusions (believing peers and teachers were conspiring against her). She also reported recurrent suicidal ideation and several self-harming behaviors prior to admission. In addition, she complained of “poor sleep” and difficulty falling asleep. Collateral history revealed repeated episodes of complex sleep-related behaviors, including sleepwalking and vocalizations, in the school dormitory prior to hospitalization. On examination, she appeared withdrawn, with a depressed affect, psychomotor delay, impaired memory and concentration, and partial insight. Multiple self-inflicted scars were observed on her forearms. Her vital signs were stable. Neurological examination revealed no focal deficits, and electroencephalogram (EEG) revealed no abnormalities. There was no history of epileptic seizures, no catatonic features were observed on examination, and no extrapyramidal or other adverse reactions occurred during hospitalization. Autoimmune encephalitis was deemed unlikely on the basis of clinical and EEG findings. Her growth and development were consistent with age norms, and her premorbid personality was described as introverted and sensitive, with psychotic symptoms occurring mainly during depressive episodes. There was no family history of psychiatric or neurological disorders. Psychiatric assessment confirmed hallucinations, delusions of reference and persecution, and severe depressive symptoms (Hamilton Depression Rating Scale-17 [HAMD-17] score: 33) [6–8]. In accordance with the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), she was initially diagnosed with major depressive disorder with psychotic features, with schizoaffective disorder excluded on the basis of the temporal relationship between affective and psychotic symptoms. She was started on escitalopram (5 mg in the morning), olanzapine (5 mg at night), sustained-release lithium carbonate (0.3 g twice daily), tandospirone (5 mg twice daily), and lorazepam (0.25 mg in the morning, 0.25 mg at noon, and 1 mg at night), in accordance with clinical guidelines for severe major depressive disorder with psychotic features and acute suicidality [9] and consistent with Chinese clinical treatment practices. On Day 4, the patient’s parents reported that she had exhibited sleepwalking during the previous night, although the patient herself had no recollection of the episode. We suspected sleep behavior disorder; therefore, polysomnography (PSG) was performed. PSG showed a sleep latency of 3.5 min, N3 sleep of 81 min, REM sleep accounting for 26.2% of total sleep time, an apnea–hypopnea index of 0.1/h, and a periodic limb movement index (PLMI) of 10.9/h (Fig. 1). During REM sleep, a sudden vocalization was recorded during brief arousal. Chin EMG demonstrated phasic activity consistent with REM sleep without atonia (RWA). Sleep continuity was poor. These findings, together with the observed dream-enactment behavior, supported a diagnosis of RBD; however, the PLMI (10.9/h) did not reach the International Classification of Sleep Disorders, Third Edition (ICSD-3) threshold for clinical significance (≥ 15/h) [10]. Moreover, brain MRI (Fig. 2) revealed a 7-mm cystic lesion in the pineal region with long T1 and long T2 signal intensity (Fig. 2A and B), slightly hypointense fluid-attenuated inversion recovery (FLAIR) (Fig. 2C), and no diffusion restriction. No mass effect, hydrocephalus, or midline shift was noted. Neurosurgery and neurology consultations confirmed the diagnosis of a benign pineal cyst and advised periodic MRI surveillance, with no further investigations deemed necessary. Considering the co-occurrence of RBD and pineal cysts and acknowledging that certain atypical antipsychotics (such as olanzapine and quetiapine) and benzodiazepines (such as lorazepam) can aggravate RBD and periodic limb movements, the treatment regimen was revised on Day 7. Olanzapine was replaced with aripiprazole, lorazepam was replaced with clonazepam to minimize the risk of exacerbating RBD and periodic limb movements, and lithium was discontinued because of potential sleep disturbances, with valproate introduced as a better-tolerated mood stabilizer [11, 12]. The patient continued on escitalopram as the primary antidepressant, and valproate was added for mood stabilization. Following this adjustment, the patient no longer reported sleepwalking episodes, and abnormal sleep behaviors subsided. Because suicidality persisted, modified electroconvulsive therapy (MECT) was initiated on Day 20, with ten sessions administered over the next three weeks. By Day 43 of hospitalization, the patient had improved mood, psychotic symptoms, and sleep, with partial recovery of social and academic functioning. Her HAMD-17 score decreased to 17, indicating a 48% reduction in depressive severity. The final discharge diagnoses were major depressive disorder with psychotic features, RBD, and pineal cysts. The clinical timeline, including key assessments, treatments, and outcomes, is summarized in Table 1 and visually presented in Fig. 3. Polysomnography showing REM sleep without atonia and dream-enactment behaviors, supporting the diagnosis of REM sleep behavior disorder (RBD). PLM: Periodic limb movements Brain MRI showing a pineal cyst measuring approximately 7 mm in diameter (red arrows indicate the cyst location). (A) T1-weighted image (T1WI) demonstrating a cystic lesion with long T1 signal; (B) T2-weighted image (T2WI) showing long T2 signal; (C) T2-fluid attenuated inversion recovery (FLAIR) image showing slightly hypointense signal; (D) Sagittal T2WI confirming cystic morphology in the pineal region; (E) Diffusion-weighted image (DWI) and (F) apparent diffusion coefficient (ADC) map showing no diffusion restriction, consistent with a benign pineal cyst and excluding tumor or inflammatory etiology Table 1Timeline of clinical assessments, treatments, and outcomesTimeClinical assessments and eventsTreatmentClinical statusDay 1 (Admission)Three-year history of low mood, hallucinations, delusions, and suicide attempts; HAMD-17 = 33; EEG findings normal; no family psychiatric historyEscitalopram, olanzapine, lithium carbonate, tandospirone, lorazepam; supportive psychotherapySevere depressive and psychotic symptoms; poor sleep; high suicide riskDay 4 (Sleep and neuroimaging evaluation)PSG showed sleep latency of 3.5 min, N3 sleep 81 min, REM sleep 26.2% of total sleep time, and PLMI 10.9/h; MRI revealed a 7-mm pineal cystEscitalopram, olanzapine, lithium carbonate, tandospirone, lorazepam; supportive psychotherapyRBD confirmed by PSG; pineal cyst identified on MRIDays 7–19 (Medication adjustment phase)RBD suspected to be medication-exacerbated; pharmacological regimen revised accordinglySwitched olanzapine → aripiprazole; lorazepam → clonazepam; added valproate; continued escitalopram and tandospirone; supportive psychotherapyRBD symptoms monitored closely; parasomnia gradually subsided; sleep continuity improved by end of this phase; mood and psychotic symptoms remained moderate, suicide risk persistedDays 20–42(MECT and stabilization phase)Persistent suicidality despite optimized pharmacotherapy; MECT initiated (10 sessions planned)MECT initiated; maintenance pharmacotherapy; supportive psychotherapy continuedGradual reduction in suicidality; improved affect and psychotic symptoms; no recurrence of RBDDay 43 (Discharge)Clinical reassessment; HAMD-17 = 17 (≈ 48% reduction)Aripiprazole, clonazepam, valproate, escitalopram, tandospirone continuedStable mood; resolution of psychosis; maintained sleep stabilityEEG: electroencephalogram; MRI: magnetic resonance imaging; PSG: polysomnography; RBD: rapid eye movement sleep behavior disorder; PLMI: periodic limb movement index; HAMD-17: Hamilton Depression Rating Scale-17; MECT: modified electroconvulsive therapy Timeline of clinical assessments, treatments, and outcomes EEG: electroencephalogram; MRI: magnetic resonance imaging; PSG: polysomnography; RBD: rapid eye movement sleep behavior disorder; PLMI: periodic limb movement index; HAMD-17: Hamilton Depression Rating Scale-17; MECT: modified electroconvulsive therapy Clinical Timeline. Horizontal timeline visualization showing key assessments, treatments, and outcomes during the 43-day hospitalization. MRI: magnetic resonance imaging; PSG: polysomnography; RBD: rapid eye movement sleep behavior disorder; MECT: modified electroconvulsive therapy Discussion This case illustrates the diagnostic and therapeutic challenges in an adolescent with major depressive disorder, psychotic symptoms, and sleep disturbance, in whom neuroimaging revealed a pineal cyst. Although pineal cysts are often incidental findings, emerging evidence has suggested a potential association between pineal abnormalities and mood disorders, including depression and sleep disturbances [13]. In this patient, the co-occurrence of RBD, hallucinations, persecutory delusions, and suicidality raised the question of whether the cyst might be associated with her clinical presentation. The situation was further complicated by the fact that she was initially treated with medications—olanzapine and lorazepam—that are reported to exacerbate RBD and periodic limb movements. Soon after treatment began, she experienced sleepwalking and dream-enactment behaviors, which prompted further investigation. PSG confirmed RBD, and MRI revealed a pineal cyst, leading to a re-evaluation of the treatment plan. Pineal cysts are thought to interfere with melatonin secretion, and melatonin plays a crucial role in both circadian rhythm regulation and emotional processing. As melatonin provides the primary hormonal signal for synchronizing the sleep–wake cycle, structural alterations of the pineal gland may consequently affect circadian timing and may also be relevant to the occurrence of RBD [14]. Ferri et al. [15] reported that patients with pineal cysts may show blunted nocturnal melatonin peaks and prolonged morning secretion, possibly due to structural disruption of pineal tissue. Such abnormalities can destabilize the sleep–wake cycle and may worsen mood disorders. Recent clinical evidence has indicated that patients with RBD commonly exhibit reduced nocturnal melatonin levels and altered circadian melatonin timing, underscoring the close physiological relationship between melatonin signaling and the pathophysiology of RBD [16]. Complementing these physiological observations, neuroimaging research has indicated that reduced pineal parenchyma volume is associated with increased severity of RBD symptoms and an increased risk of incident RBD, suggesting that alterations in pineal function—and consequently melatonin regulation—may contribute to REM sleep dysregulation [17]. Experimental studies have also suggested that melatonin exerts neuroprotective effects by modulating oxidative stress and preserving hippocampal neurons, thereby supporting mood regulation [18]. However, the mechanisms through which pineal pathology, circadian disruption—including RBD—and psychiatric symptoms are related to one another remain unknown. In addition, from a neurodevelopmental perspective, adolescence is a critical period for neurodevelopment, particularly concerning the maturation of the pineal gland and limbic system, both of which are essential for circadian and emotional regulation [19]. Disturbance of these processes may increase vulnerability to both mood and sleep disorders. Recognition of RBD in this patient was equally important. In psychiatric practice, RBD is often overlooked or misattributed to medication side effects, yet it can significantly impact quality of life. RBD-like behaviors have also been reported to occur or worsen in psychiatric patients receiving psychotropic medications [20]. In this case, the patient’s sleep-related behaviors worsened during treatment with olanzapine and lorazepam and gradually improved after these were replaced with aripiprazole and clonazepam. Clonazepam is considered a first-line pharmacotherapy for RBD because of its effectiveness in reducing dream enactment behaviors [21], and compared with other antipsychotics, aripiprazole has a more favorable sleep profile [22]. Melatonin, which helps restore circadian regulation and reduce REM-related motor activity, is also considered a relatively safer option for RBD; however, it was not used in this case, as the patient responded well to clonazepam [23]. This pharmacological adjustment, combined with ongoing antidepressant therapy and valproate for mood stabilization, led to a marked improvement in sleep continuity. Nevertheless, owing to persistent suicidality, MECT was initiated as an adjunctive treatment, with subsequent amelioration of mood and psychotic symptoms. This case emphasizes several lessons. First, in adolescents diagnosed with major depressive disorder presenting with complex psychiatric symptoms, early structural neuroimaging should be considered, as structural findings—even when incidental—can aid diagnostic formulation and guide management in cases involving mood or sleep dysregulation [24]. While pineal cysts are often incidental findings, they may represent overlooked concurrent findings in cases of circadian disruption and emotional dysregulation. In this case, MRI revealed a 7-mm pineal cyst; although it did not cause a mass effect, it might have been associated with disruptions in melatonin production or sleep–wake stability. Second, clinicians should remain cautious about prescribing medications known to worsen RBD and actively monitor for new or worsening sleep-related symptoms. Finally, management should be multidisciplinary and integrate psychiatry, neurology, sleep medicine, and neuroimaging expertise to tailor treatment for complex cases. There are also limitations to consider. Pineal cysts could still represent an incidental finding unrelated to the patient’s psychiatric symptoms or RBD, and no causal relationship can be established on the basis of a single case. However, a possible confounding role of the pineal cyst cannot be ruled out, given its association with circadian and mood–sleep regulation. Notably, the proposed link to circadian disruption is hypothetical, as melatonin levels were not assessed in this patient. Her improvement may have resulted primarily from changes in psychotropic medications and neuromodulation rather than any direct effect of the cyst. Long-term follow-up is warranted to provide additional clinical insight into the stability of the cyst and the recurrence of psychiatric or sleep-related symptoms. Despite these uncertainties, this case demonstrates the value of integrating neuroimaging and sleep assessment into the evaluation of adolescents with unusual psychiatric presentations, and it highlights the importance of tailoring pharmacological choices to minimize the risk of worsening RBD. Conclusion In this case we report an adolescent with major depressive disorder with psychotic features and coexisting RBD in the context of a pineal cyst. The co-occurrence of these conditions highlights the importance of neuroimaging in unusual psychiatric presentations and careful pharmacological selection to prevent the worsening of sleep-related symptoms. Multimodal and individualized treatment contributes to symptomatic improvement, highlighting a need for further research into pineal–circadian mechanisms in mood and sleep disorders. Supplementary Information Below is the link to the electronic supplementary material. Supplementary Material 1 Acknowledgements The authors thank the clinical staff of the Second People’s Hospital of Guizhou Province for their support in patient care and data collection. Abbreviations Magnetic resonance imaging Rapid eye movement REM sleep behavior disorder Electroencephalogram Hamilton Depression Rating Scale-17 Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition Polysomnography Periodic limb movement index REM sleep without atonia International Classification of Sleep Disorders, Third Edition Fluid attenuated inversion recovery Modified electroconvulsive therapy Author contributions Yanping Shu and Qin Zhang contributed to the collection and interpretation of clinical and imaging data. Yongzhe Hou and Jiaoying Liu conceptualized the study, designed the case report, and revised the manuscript. Yanping Shu and Jiaoying Liu wrote the main manuscript text. Qin Zhang prepared Figs. 1 and 2. Yongzhe Hou prepared Table 1; Figure 3. Jiaoying Liu, Qin Zhang, and Yongzhe Hou serve as co-corresponding authors for this manuscript. All authors reviewed and approved the final manuscript. Funding This study was supported by the National Natural Science Foundation of China (No. 82460282); Guizhou Provincial Science and Technology Program (Qiankehe Foundation: MS [2025] 025); Guizhou Provincial Science and Technology Program (Qiankehe Foundation: ZK[2023]General 195); the High-level Innovative Talent Program of Guizhou Province (Thousand-Level Talent Project, No. gzwjrs2022-013); Provincial Key Medical Discipline Construction Project of the Guizhou Provincial Health Commission in 2025-2026 (No. 2025-1), Key Advantageous Discipline Construction Projiect of Guizhou Provincial Health Commission in 2025, and the Science and Technology Fund Project of Guizhou Provincial Health Commission (No. gzwkj2025-045). Data availability This article contains the key data collected in the course of this study. The datasets utilized for the present research can be obtained from the corresponding author upon reasonable request. All figures and tables employed in the study are original works created by the authors themselves. Declarations Ethics approval and consent to participate This study involved human participants. After confirming that the patient and her parents fully understood the above information (the treatment plan and agreement to publish the case), the mother (as the legal guardian) and the patient jointly signed the written consent form. Consent for publication Written informed consent was obtained from the patient and her parents’ authorized representative for the publication of this case report in accordance. Competing interests The authors declare no competing interests. Footnotes Co-corresponding authors: Qin Zhang, Jiaoying Liu and Yongzhe Hou. Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Contributor Information Qin Zhang, Email: 1402974053@qq.com. Yongzhe Hou, Email: tedyong@163.com. Jiaoying Liu, Email: liujiaoying0418@163.com. References Associated Data Supplementary Materials Supplementary Material 1 Data Availability Statement This article contains the key data collected in the course of this study. The datasets utilized for the present research can be obtained from the corresponding author upon reasonable request. All figures and tables employed in the study are original works created by the authors themselves.